Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;44(5):544-554.
doi: 10.1002/pd.6552. Epub 2024 Mar 18.

Eliminating first trimester combined testing: Consequences for early detection of significant fetal anomalies

M A Lugthart  1   2 , H Heinrich  1   2 , I Ertugrul  1 , E N Nsiah-Asare  1 , K van de Kamp  1 , I H Linskens  2   3 , M C van Maarle  4 , E van Leeuwen  1   2 , E Pajkrt  1   2
Affiliations

Eliminating first trimester combined testing: Consequences for early detection of significant fetal anomalies

M A Lugthart et al. Prenat Diagn. 2024 May.

Abstract

Objective: To determine whether implementation of cell-free DNA (cfDNA) testing for aneuploidy as a first-tier test and subsequent abolition of first trimester combined testing (FCT) affected the first trimester detection (<14 weeks) of certain fetal anomalies.

Methods: We performed a geographical cohort study in two Fetal Medicine Units between 2011 and 2020, including 705 fetuses with prenatally detected severe brain, abdominal wall and congenital heart defects. Cases were divided into two groups: before (n = 396) and after (n = 309) cfDNA introduction. The primary outcome was the first trimester detection rate (<14 weeks) overall and for non-chromosomal anomalies solely.

Results: Overall, gastroschisis, AVSD and HLHS were detected more often in the first trimester in the before group compared to the after group, respectively 54.5% versus 18.5% (p = 0.004), 45.9% versus 26.9% (p = 0.008) and 30% versus 3.4% (p = 0.005). After exclusion of chromosomal anomalies identifiable through cfDNA testing, the detection of AVSD remained higher in the before group (43.3% vs. 9.5%, p = 0.02), leading to a possible earlier gestation at termination. The termination of pregnancy (TOP) rate did not differ among the groups. In the after group, referrals for suspected anomalies following a dating scan between 11 and 14 weeks significantly increased from 17.4% to 29.1% (p < 0.001).

Conclusion: This study underscores the value of a scan dedicated to fetal anatomy in the first trimester as we observed a decline in the early detection of certain fetal anomalies (detectable in the first trimester) subsequent to the abolition of FCT.

PubMed Disclaimer

References

REFERENCES

    1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet (London, England). 1997;350(9076):485‐487. https://doi.org/10.1016/s0140‐6736(97)02174‐0
    1. Chandrasekharan S, Minear MA, Hung A, Allyse M. Noninvasive prenatal testing goes global. Sci Transl Med. 2014;6(231):231fs215. https://doi.org/10.1126/scitranslmed.3008704
    1. Gregg AR, Skotko BG, Benkendorf JL, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18(10):1056‐1065. https://doi.org/10.1038/gim.2016.97
    1. Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH. Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis. Ultrasound Obstet Gynecol: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2015;45(3):249‐266. https://doi.org/10.1002/uog.14791
    1. Iwarsson E, Jacobsson B, Dagerhamn J, Davidson T, Bernabé E, Heibert Arnlind M. Analysis of cell‐free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population ‐ a systematic review and meta‐analysis. Acta Obstet Gynecol Scand. 2017;96(1):7‐18. https://doi.org/10.1111/aogs.13047

Substances

LinkOut - more resources